Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product & Service (Instruments, Consumables, Services), By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing), By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), By Region & Competition, 2020-2030F
Market Overview
The Global Whole Genome Sequencing (WGS) Market was valued at USD 2.05 billion in 2024 and is expected t%li%reach USD 4.09 billion by 2030, growing at a CAGR of 12.15% during the forecast period. WGS has become a foundational tool across genomics, personalized medicine, diagnostics, and research, owing t%li%its ability t%li%analyze an organism’s entire genetic blueprint. Continuous advancements in sequencing technology, increased throughput, and declining costs are expanding WGS adoption across diverse sectors including healthcare, agriculture, and forensics. The growing integration of WGS in clinical diagnostics and expanding public and private investments in genomics are further driving market momentum. While challenges such as high costs, data management complexity, and regulatory compliance remain, the integration of AI and machine learning, along with the emergence of new applications, is expected t%li%accelerate the market’s growth trajectory.
Key Market Drivers
Increasing Prevalence of Genetic Disorders
The rise in genetic disorders globally is a key factor propelling the adoption of whole genome sequencing. Genetic conditions affect approximately 2–5% of live births, with a considerable global impact on childhood morbidity and mortality. With up t%li%80 million individuals estimated t%li%be living with rare genetic disorders worldwide, the need for comprehensive diagnostic tools is escalating. WGS enables precise identification of genetic mutations, offering superior accuracy compared t%li%traditional diagnostic methods. In countries like India, where nearly one million infants are born annually with genetic disorders—many undiagnosed—the use of WGS allows clinicians t%li%detect conditions early and implement targeted treatments. This ability t%li%provide early diagnosis, personalized care, and improved clinical outcomes positions WGS as a critical solution amid rising genetic health concerns.
Key Market Challenges
High Cost of Whole Genome Sequencing
Although sequencing costs have significantly declined, the overall expense associated with WGS remains a substantial barrier t%li%widespread adoption, especially in low- and middle-income regions. While sequencing a genome can now be achieved for under $1,000, ancillary costs such as data analysis, storage, and advanced computational infrastructure add t%li%the financial burden. Institutions must als%li%invest in trained personnel t%li%interpret complex genomic data. These cost-related challenges can limit access t%li%WGS in smaller hospitals and research facilities, despite its long-term benefits in enhancing healthcare outcomes. This financial barrier continues t%li%restrict the market’s accessibility and full-scale integration int%li%routine clinical practices.
Key Market Trends
Integration of Artificial Intelligence and Machine Learning in Genomic Data Analysis
A transformative trend in the WGS market is the growing use of artificial intelligence (AI) and machine learning (ML) for genomic data interpretation. The immense volume of data generated by WGS requires advanced analytics t%li%extract meaningful insights. AI and ML technologies can identify complex patterns, predict mutation effects, and enhance the precision of personalized treatment strategies. These tools are revolutionizing clinical decision-making, enabling faster and more accurate diagnoses, supporting drug discovery, and optimizing research workflows. As AI-driven solutions continue t%li%evolve, they will play a crucial role in scaling the utility of WGS across both clinical and research applications, enhancing efficiency and expanding its real-world impact.
Key Market Players
In this report, the Global Whole Genome Sequencing Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.
Available Customizations:
Global Whole Genome Sequencing market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
The Global Whole Genome Sequencing (WGS) Market was valued at USD 2.05 billion in 2024 and is expected t%li%reach USD 4.09 billion by 2030, growing at a CAGR of 12.15% during the forecast period. WGS has become a foundational tool across genomics, personalized medicine, diagnostics, and research, owing t%li%its ability t%li%analyze an organism’s entire genetic blueprint. Continuous advancements in sequencing technology, increased throughput, and declining costs are expanding WGS adoption across diverse sectors including healthcare, agriculture, and forensics. The growing integration of WGS in clinical diagnostics and expanding public and private investments in genomics are further driving market momentum. While challenges such as high costs, data management complexity, and regulatory compliance remain, the integration of AI and machine learning, along with the emergence of new applications, is expected t%li%accelerate the market’s growth trajectory.
Key Market Drivers
Increasing Prevalence of Genetic Disorders
The rise in genetic disorders globally is a key factor propelling the adoption of whole genome sequencing. Genetic conditions affect approximately 2–5% of live births, with a considerable global impact on childhood morbidity and mortality. With up t%li%80 million individuals estimated t%li%be living with rare genetic disorders worldwide, the need for comprehensive diagnostic tools is escalating. WGS enables precise identification of genetic mutations, offering superior accuracy compared t%li%traditional diagnostic methods. In countries like India, where nearly one million infants are born annually with genetic disorders—many undiagnosed—the use of WGS allows clinicians t%li%detect conditions early and implement targeted treatments. This ability t%li%provide early diagnosis, personalized care, and improved clinical outcomes positions WGS as a critical solution amid rising genetic health concerns.
Key Market Challenges
High Cost of Whole Genome Sequencing
Although sequencing costs have significantly declined, the overall expense associated with WGS remains a substantial barrier t%li%widespread adoption, especially in low- and middle-income regions. While sequencing a genome can now be achieved for under $1,000, ancillary costs such as data analysis, storage, and advanced computational infrastructure add t%li%the financial burden. Institutions must als%li%invest in trained personnel t%li%interpret complex genomic data. These cost-related challenges can limit access t%li%WGS in smaller hospitals and research facilities, despite its long-term benefits in enhancing healthcare outcomes. This financial barrier continues t%li%restrict the market’s accessibility and full-scale integration int%li%routine clinical practices.
Key Market Trends
Integration of Artificial Intelligence and Machine Learning in Genomic Data Analysis
A transformative trend in the WGS market is the growing use of artificial intelligence (AI) and machine learning (ML) for genomic data interpretation. The immense volume of data generated by WGS requires advanced analytics t%li%extract meaningful insights. AI and ML technologies can identify complex patterns, predict mutation effects, and enhance the precision of personalized treatment strategies. These tools are revolutionizing clinical decision-making, enabling faster and more accurate diagnoses, supporting drug discovery, and optimizing research workflows. As AI-driven solutions continue t%li%evolve, they will play a crucial role in scaling the utility of WGS across both clinical and research applications, enhancing efficiency and expanding its real-world impact.
Key Market Players
- Illumina, Inc.
- Therm%li%Fisher Scientific Inc.
- Oxford Nanopore Technologies plc.
- Pacific Biosciences of California, Inc.
- BGI
- QIAGEN
- Agilent Technologies, Inc.
- ProPhase Labs, Inc.
- Psomagen, Inc
- Azenta US Inc.
In this report, the Global Whole Genome Sequencing Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Whole Genome Sequencing Market, By Product & Service:
- Instruments
- Consumables
- Services
- Whole Genome Sequencing Market, By Type:
- Large Whole Genome Sequencing
- Small Whole Genome Sequencing
- Whole Genome Sequencing Market, By Workflow:
- Pre-sequencing
- Sequencing
- Data Analysis
- Whole Genome Sequencing Market, By Application:
- Human Whole Genome Sequencing
- Plant Whole Genome Sequencing
- Animal Whole Genome Sequencing
- Microbial Whole Genome Sequencing
- Whole Genome Sequencing Market, By End User:
- Academic & Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
- Whole Genome Sequencing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.
Available Customizations:
Global Whole Genome Sequencing market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. WHOLE GENOME SEQUENCING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Instruments, Consumables, Services)
5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTH AMERICA WHOLE GENOME SEQUENCING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Workflow
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Whole Genome Sequencing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By Workflow
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Whole Genome Sequencing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By Workflow
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Whole Genome Sequencing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By Workflow
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. EUROPE WHOLE GENOME SEQUENCING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Workflow
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Whole Genome Sequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Workflow
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. United Kingdom Whole Genome Sequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Workflow
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Italy Whole Genome Sequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Workflow
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. France Whole Genome Sequencing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Workflow
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Whole Genome Sequencing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Workflow
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. ASIA-PACIFIC WHOLE GENOME SEQUENCING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Workflow
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Whole Genome Sequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Workflow
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Whole Genome Sequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Workflow
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Whole Genome Sequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Workflow
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Whole Genome Sequencing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Workflow
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Whole Genome Sequencing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Workflow
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. SOUTH AMERICA WHOLE GENOME SEQUENCING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Workflow
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Whole Genome Sequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Workflow
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Whole Genome Sequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Workflow
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Whole Genome Sequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Workflow
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. MIDDLE EAST AND AFRICA WHOLE GENOME SEQUENCING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By Workflow
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Whole Genome Sequencing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Workflow
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Workflow
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Whole Genome Sequencing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By Workflow
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL WHOLE GENOME SEQUENCING MARKET: SWOT ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Illumina, Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Thermo Fisher Scientific Inc.
14.3. Oxford Nanopore Technologies plc.
14.4. Pacific Biosciences of California, Inc.
14.5. BGI
14.6. QIAGEN
14.7. Agilent Technologies, Inc.
14.8. ProPhase Labs, Inc.
14.9. Psomagen, Inc
14.10.Azenta US Inc..
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. WHOLE GENOME SEQUENCING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Instruments, Consumables, Services)
5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTH AMERICA WHOLE GENOME SEQUENCING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Workflow
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Whole Genome Sequencing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By Workflow
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Whole Genome Sequencing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By Workflow
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Whole Genome Sequencing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By Workflow
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. EUROPE WHOLE GENOME SEQUENCING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Workflow
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Whole Genome Sequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Workflow
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. United Kingdom Whole Genome Sequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Workflow
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Italy Whole Genome Sequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Workflow
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. France Whole Genome Sequencing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Workflow
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Whole Genome Sequencing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Workflow
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. ASIA-PACIFIC WHOLE GENOME SEQUENCING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Workflow
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Whole Genome Sequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Workflow
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Whole Genome Sequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Workflow
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Whole Genome Sequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Workflow
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Whole Genome Sequencing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Workflow
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Whole Genome Sequencing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Workflow
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. SOUTH AMERICA WHOLE GENOME SEQUENCING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Workflow
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Whole Genome Sequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Workflow
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Whole Genome Sequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Workflow
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Whole Genome Sequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Workflow
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. MIDDLE EAST AND AFRICA WHOLE GENOME SEQUENCING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By Workflow
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Whole Genome Sequencing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Workflow
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Workflow
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Whole Genome Sequencing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By Workflow
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL WHOLE GENOME SEQUENCING MARKET: SWOT ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Illumina, Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Thermo Fisher Scientific Inc.
14.3. Oxford Nanopore Technologies plc.
14.4. Pacific Biosciences of California, Inc.
14.5. BGI
14.6. QIAGEN
14.7. Agilent Technologies, Inc.
14.8. ProPhase Labs, Inc.
14.9. Psomagen, Inc
14.10.Azenta US Inc..
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
